| Predicate |
Object |
| contentType |
Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review |
| endingPage |
338 |
| issn |
0340-7004
1432-0851 |
| issueIdentifier |
3 |
| pageRange |
329-338 |
| publicationName |
Cancer immunology, immunotherapy : CII |
| startingPage |
329 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6913d2468615f2061021622b70f226a4
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_61fbd4fbefa2824db199af5a4d79988f |
| bibliographicCitation |
Zeng Y, Graner MW, Katsanis E. Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunol Immunother. 2006 Mar;55(3):329–38. doi: 10.1007/s00262-005-0694-1. PMID: 15887013. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09b25e7c8bb831341a45462fb5936426
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff04fa92cfbe38c6a820ac16f76aa485
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8f5ce6839ddf10265336b1cf00ab5cc |
| date |
2005-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/15887013
https://doi.org/10.1007/s00262-005-0694-1 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0340-7004
https://portal.issn.org/resource/ISSN/1432-0851
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2781 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Chaperone-rich cell lysates, immune activation and tumor vaccination |
| discusses |
http://id.nlm.nih.gov/mesh/M0028986
http://id.nlm.nih.gov/mesh/M0009986
http://id.nlm.nih.gov/mesh/M0001435 |